Fundraising Fox

Igenica Biotherapeutics

Burlingame, US · Delaware corporation · 3 known investors

Biotech

Founders & leadership

RS
Robert SchreiberDirector
JC
John CelebiExecutive Officer
JD
John DiekmanDirector
MG
Mark GoldsmithDirector
CG
Carl GordonDirector
DG
David GoeddelDirector
GF
Gwen FyfeDirector

Investors · 3

5AM VenturesreportedBoston · $100K – $4Mvia John Diekman · board
OrbiMedreportedNew York · $1M – $75Mvia Carl Gordon · board
The Column GroupreportedSan Francisco · $30Mvia David Goeddel · board

Reported raises · per SEC filings

Form D private placements
▶$2.3MraisedOct 2015 · 10 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark GoldsmithDirector
  • John CelebiExecutive Officer
  • John DiekmanDirector
  • Robert SchreiberDirector
  • David GoeddelDirector
  • Gwen FyfeDirector
Offering amount
$5M
Amount sold
$2.3M
First sale
Sep 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.2MraisedJun 2015 · 8 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark GoldsmithDirector
  • David GoeddelDirector
  • Gwen FyfeDirector
  • Robert SchreiberDirector
  • John CelebiExecutive Officer
  • John DiekmanDirector
Offering amount
$4M
Amount sold
$1.2M
First sale
May 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.1MraisedJan 2015 · 10 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert SchreiberDirector
  • John CelebiExecutive Officer
  • John DiekmanDirector
  • Mark GoldsmithDirector
  • Carl GordonDirector
  • David GoeddelDirector
  • Gwen FyfeDirector
Offering amount
$6.3M
Amount sold
$5.1M
First sale
Jan 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.